GT Biopharma (GTBP) Current Leases (2019 - 2024)
GT Biopharma (GTBP) posted quarterly Current Leases of $30000.0 for Q1 2024, down 74.14% year-over-year from $116000.0 in Q2 2023, and down 48.28% quarter-over-quarter from $58000.0 in Q4 2023.
GT Biopharma (GTBP) Current Leases (2019 - 2024) Analysis & Trends
GT Biopharma (GTBP) has reported Current Leases for 5 consecutive years, with $30000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Current Leases fell 74.14% year-over-year to $30000.0; the TTM figure through Mar 2024 stood at $30000.0 (down 74.14% YoY), while the FY2023 annual figure was $58000.0, down 47.27% from the prior year.
- Current Leases eased to $30000.0 in Q1 2024 per GTBP's latest filing, from $58000.0 in the prior quarter.
- Across five years, Current Leases topped out at $120000.0 in Q2 2023 and bottomed at $30000.0 in Q1 2024.
- Historically, Current Leases has averaged $92666.7 across 4 years, with a median of $101500.0 in 2022.
- Annual changes were most pronounced in 2023 — Current Leases rose 16.5% — and 2024, when it slumped 74.14%.
- GT Biopharma's Current Leases stood at $82000.0 in 2020, then soared by 34.15% to $110000.0 in 2022, then slumped by 47.27% to $58000.0 in 2023, then plunged by 48.28% to $30000.0 in 2024.
- Business Quant data shows GTBP's Current Leases at $30000.0 in Q1 2024, $58000.0 in Q4 2023, and $92000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | GT Biopharma | 8.82 Mn | 8.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 110,000.00 |
| Sep 30, 2022 | 106,000.00 |
| Jun 30, 2022 | 103,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Sep 30, 2020 | 82,000.00 |
| Jun 30, 2020 | 90,000.00 |
| Mar 31, 2020 | 105,000.00 |
| Dec 31, 2019 | 120,000.00 |
| Sep 30, 2019 | 134,000.00 |
| Jun 30, 2019 | 147,000.00 |
| Mar 31, 2019 | 161,000.00 |